1. Home
  2. INCR

INCR

Intercure Ltd.

Logo Intercure Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-15-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.

Founded: 1994 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 107.6M IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 93.0K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.12 EPS Growth: N/A
52 Week Low/High: $0.99 - $2.92 Next Earning Date: 05-13-2024
Revenue: $112,409,756 Revenue Growth: 28.06%
Revenue Growth (this year): -1.14% Revenue Growth (next year): -11.05%

Share on Social Networks: